Literature DB >> 25755490

Polymorphisms in ABCB11 and ATP8B1 Associated with Development of Severe Intrahepatic Cholestasis in Hodgkin's Lymphoma.

Laura Blackmore1, A S Knisely2, Jane L Hartley3, Kirsten McKay4, Paul Gissen5, Robert Marcus6, Debbie L Shawcross1.   

Abstract

We report a young man presenting with jaundice and severe debilitating intrahepatic cholestasis 7 months before the diagnosis of Hodgkin's lymphoma. Serum gamma-glutamyl transferase (GGT) activity was not raised. Liver biopsy demonstrated deficiency of canalicular GGT and bile salt export pump expression, which suggested "benign" recurrent intrahepatic cholestasis. Direct sequencing of genomic DNA was therefore undertaken to look for mutations in ATP8B1 and ABCB11. Cholestasis and pruritus are well recognized presenting features of Hodgkin's lymphoma. However, striking in this case is that the intrahepatic cholestasis presented and resolved 7 months before the diagnosis. Furthermore, 4 polymorphisms were identified in ATP8B1 in this patient-c.696T > C (rs319438), c.811A > C (rs319438), c.2855G > A (rs1296811) and c.3454G > A (rs222581)-and two polymorphisms in ABCB11-c.1331T > C (rs2287622) and c.3084A > G (rs497692); 2 of which have been associated with intrahepatic cholestasis of pregnancy. We therefore postulate that these polymorphisms predisposed this patient to the development of intrahepatic cholestasis within the abnormal pro-inflammatory cytokine milieu typical for Hodgkin's lymphoma. This case shows for the first time that some polymorphisms in ABCB11 and ATP8B1 may predispose to the development of intrahepatic cholestasis in Hodgkin's lymphoma. It also demonstrates the importance of close clinical surveillance for the development of Hodgkin's lymphoma in patients presenting with unexplained intrahepatic cholestasis.

Entities:  

Keywords:  BRIC, “benign” recurrent intrahepatic cholestasis; BSEP, bile salt export pump; CT, computerized tomography; GGT, gamma-glutamyl transferase; Hodgkin's; ICP, intrahepatic cholestasis of pregnancy; PFIC, progressive familial intrahepatic cholestasis; UDCA, ursodeoxycholic acid; intrahepatic cholestasis; lymphoma; polymorphism

Year:  2013        PMID: 25755490      PMCID: PMC3940180          DOI: 10.1016/j.jceh.2013.01.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  3 in total

1.  Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.

Authors:  Stefan K Barta; Joachim Yahalom; Jinru Shia; Paul A Hamlin
Journal:  Clin Lymphoma Myeloma       Date:  2006-07

Review 2.  Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.

Authors:  Ari Ballonoff; Brian Kavanagh; Russell Nash; Harry Drabkin; James Trotter; Luciano Costa; Rachel Rabinovitch
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

3.  Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy.

Authors:  P H Dixon; S W C van Mil; J Chambers; S Strautnieks; R J Thompson; F Lammert; R Kubitz; V Keitel; A Glantz; L-A Mattsson; H-U Marschall; M Molokhia; G E Moore; K J Linton; C Williamson
Journal:  Gut       Date:  2008-11-05       Impact factor: 23.059

  3 in total
  2 in total

1.  Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis.

Authors:  Turan Çalhan; Elif Yivli
Journal:  Clin Case Rep       Date:  2022-03-10

Review 2.  Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature.

Authors:  Ioannis Papakonstantinou; Maria Kosmidou; Konstantina Papathanasiou; Epameinondas Koumpis; Eleni Kapsali; Haralampos Milionis; Theodoros P Vassilakopoulos; Alexandra Papoudou-Bai; Eleftheria Hatzimichael
Journal:  In Vivo       Date:  2021 Jul-Aug       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.